₹115.68▼ −0.21 · −0.2%from ₹115.89 the session before · 1 Oct 2026 close · NSE end of day
Open
₹116.60
High
₹116.60
Low
₹114.65
Day's range
₹1.91.7% of the previous close
VWAP
₹115.83close −0.13% from it
Volume, shares
5,9000.70× the 20-session average
Turnover, ₹ crore
0.07
Trades
13046 shares per trade
Previous close
₹115.89−0.21 to the close
Price band, next session
₹104.10 – ₹127.2510% either side of the close · dynamic, widened in 5% steps when hit
Day range53% of the way up
₹114.65₹116.60
52-week range37% of the way up
₹97.59 30 Mar₹147.00 30 Jan
−21% from the high · +19% from the low
Futures and options
No derivatives listed on LOTUSEYE
Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it
Revenue ₹17 cr; profit ₹1 cr in the Jun 2026 quarter, standalone.
Last 2 quarters, standalone₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of LOTUSEYE on the standalone basis with the market's move on the first session after each filing
Quarter
Revenue ₹ cr
Revenue YoY
Profit ₹ cr
Profit YoY
EPS ₹
Market on the day
Jun 2026filed 10 Aug
₹17 cr
—
₹1 cr
—
0.30
▲ +3.6%Nifty −0.5% · +4.1 pp
Mar 2026filed 26 May · audited
₹14 cr
—
−₹0 cr
—
-0.15
▼ −1.0%Nifty 0.0% · −1.0 pp
Fundamentals
standalone · filings to Jun 2026 · close ₹115.68 on 1 Oct
4.0 times book value, market cap ₹240 cr.
Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
₹240 cron 1 Oct · free float ₹140 cr
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
4.0standalone · balance sheet to Mar 2026
Book value a share
₹28.92standalone · balance sheet to Mar 2026 · over NSE's share count
Debt to equity
0.19borrowings over equity · standalone · balance sheet to Mar 2026
Return on equity
—needs two filed balance sheets
Dividend yield
—no dividend with an ex-date in 365 days
Face value
₹10a share
Shares outstanding
2 cron 1 Oct
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · standalone
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed
PeersBSE sub-group Hospital · F&O stocks with filings on record · industry P/E 58, market caps over trailing profit of 4 stocks
Stocks in the BSE sub-group Hospital with market cap, price to earnings and price to book
quarter to 30 Jun · 87% of the promoter holding pledged · NSE filings
Promoters hold 40.1%, banks and financial institutions 0.0%, individual investors 36.7% and others 23.1%, as filed for the quarter to 30 Jun.
40.1%36.7%23.1%
Promoters 40.1%
Banks and financial institutions 0.0%
Individual investors 36.7%
Others 23.1%
By category, last 2 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of LOTUSEYE by category over the last 2 quarters with the change against the previous quarter
Category
30 Jun
31 Mar
Promoters
40.140.00 pp
40.14
Banks and financial institutions
0.020.00 pp
0.02
Individual investors
36.70▼ −0.39 pp
37.09
Bodies corporate
13.77▲ +0.28 pp
13.49
Others
9.38▲ +0.11 pp
9.27
Corporate actions
NSE and BSE records
No corporate action on record for LOTUSEYE yet.
Price history
206 sessions on record · to 1 Oct · NSE end of day
LOTUSEYE is +7.1% over 20 sessions against Nifty's −6.2%, 21% below its 52-week high, realised volatility 25% annualised.
Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
Window
From ₹
LOTUSEYE %
Nifty 50 %
Difference pp
120 sessionssince 9 Apr
₹108.87
▲ +6.3%
▼ −5.7%
+12
60 sessionssince 8 Jul
₹118.56
▼ −2.4%
▼ −6.1%
+3.7
20 sessionssince 2 Sept
₹107.98
▲ +7.1%
▼ −6.2%
+13
5 sessionssince 24 Sept
₹113.23
▲ +2.2%
▼ −2.8%
+4.9
1 sessionsince 30 Sept
₹115.89
▼ −0.18%
▼ −0.88%
+0.70
Averages of the closeclose against each average
5-session average
₹114.92close +0.66% from it
20-session average
₹113.07close +2.3% from it
50-session average
₹114.69close +0.86% from it
200-session average
₹116.49close −0.70% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹3.63.1% of the close
Average day's range, 20
₹3.63.1% of the close
Volume against 20 sessions
0.70×5,900 vs 8,100 average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
25%≈ ±1.6% a session · moved more than that on 7 of 20
Realised volatility, 60
25%≈ ±1.6% a session · moved more than that on 18 of 60
Beta to Nifty, 60
0.33moved with Nifty on 32 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
12 up · 8 downof 20
Last 60 sessions
25 up · 35 downof 60
Best session, 250
▲ +14%5 Jun
Worst session, 250
▼ −18%8 Dec
0 bulletins on LOTUSEYE
The desk has not written about Lotus Eye Hospital and Institute Limited yet. The tape carries every bulletin as it is published.
About Lotus Eye Hospital and Institute Limited
exchange masters as of 18 Sept 2026 · classification by BSE
Company
Lotus Eye Hospital and Institute Limited
Exchange
NSE · BSE 532998, group B
Listed on NSE
11 Jul 2008
Classification
Healthcare › Healthcare Services › Hospital
Face value
₹10 a share
ISIN
INE947I01017
Sessions on record
206
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
2 Oct, 01:46 am IST
Bulletins
0 · written by the desk · not a recommendation
OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.